Star Therapeutics
San Francisco
CA
94115
United States
7 articles about Star Therapeutics
-
Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer
1/3/2024
Star Therapeutics today announced the appointment of Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer.
-
Star Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
1/2/2024
Star Therapeutics today announced that Adam Rosenthal, Ph.D., CEO and Founder, will present a company overview at the 42nd annual J.P. Morgan Healthcare Conference on Thursday, January 11th at 10:30 a.m. PT.
-
Star Therapeutics Appoints Matthew Fust as Independent Director and Board Audit Chair
12/5/2023
Star Therapeutics today announced the appointment of Matthew Fust, a veteran finance executive in the life sciences industry, to its Board of Directors.
-
Star Therapeutics Raises $90 Million Financing to Accelerate Its Pipeline of Novel Antibody Therapies and Growth of Its Portfolio Companies
9/5/2023
Star Therapeutics, a biotechnology company interrogating novel biology to develop life-changing therapies, today announced the closing of an oversubscribed $90 million Series C financing to continue growth of its first-in-class antibody therapies and portfolio companies.
-
Star Therapeutics emerges from stealth mode raising $100M in financing since inception to be an innovation engine for rare disease therapies
2/16/2022
Star Therapeutics has formed a family of companies, and Electra Therapeutics is the first to be spun out with a lead monoclonal antibody in Phase 1 clinical development.
-
Star Therapeutics has exited stealth mode and announced a spin-off company, Electra Therapeutics.
-
Money on the Move: February 9 – 15
2/16/2022
As the market seems to be taking a turn against biotech stock, more companies are opting for private funding instead of going public for the moment. And VC firms are happy to jump in.